Late stage trials into a coronavirus vaccine developed by Oxford University and drugmaker AstraZeneca were paused after a woman who received the experimental shot developed severe neurological symptoms.
Pharma giant AstraZeneca and Oxford University on Saturday said they had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a United Kingdom volunteer falling ill.
AstraZeneca and the University of Oxford, as the trial sponsor, on Saturday said that they can not disclose further medical information but confirmed that independent investigations concluded that the trials were safe to restart.
Corticosteroids Can Be Used In COVID-19 Treatment, New Studies Show
One study included in the meta-analysis found that corticosteroids might even increase mortality in non-severe patients. Three studies have shown that these anti-inflammatory drugs can improve the survival of the sickest COVID-19 patients .
"We are committed to the safety of our participants and the highest standards of conduct in our studies, and will continue to monitor safety closely", the University of Oxford said in a separate statement on Saturday.
"In large trials illnesses will happen by chance but must be independently reviewed to check this carefully", the University of Oxford had said in an official statement.
AstraZeneca's vaccine candidate is one of nine around the world now in late-stage Phase 3 human trials.
No details about the patient or the nature of the side effect were given.
Nine new cases of Covid-19 in Kildare today
Of the cases notified today 160 are men and 146 are women while 73% are under 45 years of age. There is now a total of 29,672 confirmed cases of COVID-19 in Ireland.
He said the trial was going well, but unfortunately a few days ago the news came out that it had been halted because one of the recipients developed a case of transverse myelitis, which is an inflammatory condition of the spinal cord which causes sensory and motor deficits.
The Oxford University's Jenner Institute team started working to develop a vaccine against the SARS-CoV-2, or the virus which causes COVID-19 in January this year and says it has been working with unprecedented urgency in a race against the coronavirus. It has also authorised emergency usage of COVID-19 vaccines developed by some select domestic companies. The first batches of the vaccine have been sent to all of the country's regions to test the supply system, Russia's Health Minister Mikhail Murashko said on Saturday.
Scientists and others around the world, including experts at the World Health Organization, have sought to keep a lid on expectations of an imminent breakthrough for coronavirus vaccines, stressing that vaccine trials are rarely straightforward.
The AstraZeneca /Oxford partnership is one of the vaccine development efforts against the coronavirus that is furthest along.
Apple's 'Most Affordable' iPhone 12 5G Starts Its Production Later This Month
Apple has just dropped a teaser to its upcoming, online-only hardware launch event, scheduled to take place on September 15th. Apple also plans to announce the first Mac running its own processors, replacing Intel Corp., before the end of the year.